Karschnia, Philipp, Young, Jacob S., Wijnenga, Maarten, Wagner, Arthur, Schnell, Oliver, Haeni, Levin, Esquenazi, Yoshua, Vik-Mo, Einar, Ruda, Roberta, Vogelbaum, Michael A., Hervey-Jumper, Shawn L., Beck, Juergen, Dietrich, Jorg, Grau, Stefan J., Park, Yae Won, Youssef, Gilbert, Jakola, Asgeir, Bello, Lorenzo, Berger, Mitchel S.
och Tonn, Joerg, A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: A report by the RANO resect group., JOURNAL OF CLINICAL ONCOLOGY, 2025, : LIPPINCOTT WILLIAMS & WILKINS
Karschnia, Philipp, Young, Jacob S, Wijnenga, Maarten M J, Sciortino, Tommaso, Teske, Nico, Corell, Alba, Wagner, Arthur, Youssef, Gilbert, Park, Yae Won, Häni, Levin, Jünger, Stephanie T, Dono, Antonio, Ehret, Felix, Mireles, Eduardo E Mendoza, Neidert, Nicolas, Bruno, Francesco, Tuchek, Chad A, van der Vaart, Thijs, Rossi, Marco, Nibali, Marco Conti, Gay, Lorenzo, Gramelt, Alfred, Tandon, Nitin, Ahn, Sung Soo, Chang, Jong Hee, Weller, Michael, Vincent, Arnaud J P E, Goldbrunner, Roland, Cahill, Daniel P, Huang, Raymond Y, Raabe, Andreas, Meyer, Bernhard, Beck, Juergen, Molinaro, Annette M, Chang, Susan M, Vogelbaum, Michael A, Rudà, Roberta, Vik-Mo, Einar O, Dietrich, Jorg, Esquenazi, Yoshua, Grau, Stefan J, Wen, Patrick Y, Jakola, Asgeir, Schnell, Oliver, Bello, Lorenzo, van den Bent, Martin J, Hervey-Jumper, Shawn, Berger, Mitchel S
och Tonn, Joerg-Christian, A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group., The Lancet. Oncology, 2025, 26 nr 12, s. 1638–1650
Karschnia, Philipp, Gerritsen, Jasper K W, Teske, Nico, Cahill, Daniel P, Jakola, Asgeir Store, van den Bent, Martin, Weller, Michael, Schnell, Oliver, Vik-Mo, Einar O, Thon, Niklas, Vincent, Arnaud J P E, Kim, Michelle M, Reifenberger, Guido, Chang, Susan M, Hervey-Jumper, Shawn L, Berger, Mitchel S
och Tonn, Joerg-Christian, The oncological role of resection in newly diagnosed diffuse adult-type glioma defined by the WHO 2021 classification: a Review by the RANO resect group., The Lancet Oncology, 2024, 25 nr 9, : Elsevier BV
Heggebo, Liv Cathrine, Borgen, Ida Maria Henriksen, Rylander, Hillevi, Kiserud, Cecilie, Nordenmark, TH, Hellebust, Taran Paulsen, Evensen, Morten Egeberg, Gustavsson, Magnus, Ramberg, Christina, Sprauten, Mette, Magelssen, Henriette, Blakstad, Hanne, Moorthy, Janani, Andersson, Karin, Raunert, Ingela, Henry, Thomas, Moe, Cecilie, Granlund, Carin, Goplen, Dorota, Brekke, Jorunn, Johannessen, Tor-Christian Aase, Solheim, Tora Skeidsvoll, Marienhagen, Kirsten, Humberset, Oyvind, Bergstrom, Per, Agrup, Måns, Dahl, Ludvig, Gubanski, Michael, Gojon, Helene, Brahme, Carl-Johan, Rydén, Isabelle, Jakola, Asgeir Store, Vik-Mo, Einar O., Lie, Hanne C., Asphaug, Lars, Hervani, Maziar, Kristensen, Ingrid, Rueegg, Corina Silvia, Olsen, Inge C., Ledal, Rolf J., Degsell, Eskil, Werlenius, Katja, Blomstrand, Malin, Brandal, Petter
och Nordenmark, Tonje Haug, Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden, Bmj Open, 2023, 13 nr 3, : BMJ
Munkvold, Bodil Karoline Ravn, Solheim, Ole, Bartek, Jiri, Jr., Corell, Alba, de Dios, Eddie, Gulati, Sasha, Helseth, Eirik, Holmgren, Klas, Jensdottir, M, Lundborg, Mina, Mireles, Eduardo Erasmo Mendoza, Mahesparan, Ruby, Tveiten, Oystein Vesterli, Milos, Peter, Nittby Redebrandt, Henrietta, Pedersen, Lars Kjelsberg, Ramm-Pettersen, Jon, Sjöberg, Rickard L., Sjögren, Björn, Sjavik, Kristin, Smits, Anja, Tomasevic, Gregor, Vecchio, Tomás Gomez, Vik-Mo, Einar O., Zetterling, Maria, Salvesen, Oyvind
och Jakola, Asgeir Store, Variations in the management of diffuse low-grade gliomas : A Scandinavian multicenter study, Neuro-Oncology Practice, 2021, 8 nr 6, s. 706–717, : Oxford University Press
Behnan, Jinan, Isakson, Paulin, Joel, Mrinal, Cilio, Corrado, Langmoen, Iver A, Vik-Mo, Einar O
och Badn, Wiaam, Recruited brain tumor-derived mesenchymal stem cells contribute to brain tumor progression., Stem Cells, 2014, 32 nr 5, s. 1110–1123, : Oxford University Press